Search Results

Return to List
Results 41–60 of 95
Title Date
41.

Integrating Immunizations Into Practice

Number 558

ABSTRACT: Given demonstrated vaccine efficacy, safety, and the large potential for prevention of many infectious diseases among adults, newborns, and pregnant women, obstetrician–gynecologists should...

April 2013

PDF Format
42.

Intimate Partner Violence

Number 518

ABSTRACT: Intimate partner violence (IPV) is a significant yet preventable public health problem that affects millions of women regardless of age, economic status, race, religion, ethnicity, sexual o...

February 2012

PDF Format
43.

Management of Acute Abnormal Uterine Bleeding in Nonpregnant Reproductive-Aged Women

Number 557

ABSTRACT: Initial evaluation of the patient with acute abnormal uterine bleeding should include a prompt assessment for signs of hypovolemia and potential hemodynamic instability. After initial asses...

April 2013

PDF Format
44.

Management of Vulvar Intraepithelial Neoplasia

Number 509

(Reaffirmed 2014)

ABSTRACT: Vulvar intraepithelial neoplasia (VIN) is an increasingly common problem, particularly among women in their 40s. The term VIN is used to denote high-grade squamous lesions and is subdivided...

November 2011

PDF Format
45.

Management of Women With Dense Breasts Diagnosed by Mammography

Number 593

ABSTRACT: Women with dense breasts have a modestly increased risk of breast cancer and experience reduced sensitivity of mammography to detect breast cancer. However, evidence is lacking to advocate ...

April 2014

PDF Format
46.

Marriage Equality for Same-Sex Couples

Number 574

(Replaces No. 428, February 2009)

ABSTRACT: Same-sex couples encounter barriers to health care that include concerns about confidentiality and disclosure, stigma and discriminatory attitudes and treatment, limited access to health ca...

September 2013

PDF Format
47.

Medical Futility

Number 362

(Reaffirmed 2008)

ABSTRACT: The construct of medical futility has been used to justify a physician's unilateral refusal to provide treatment requested or demanded by a patient or the family of a patient. It is importa...

March 2007

PDF Format
48.

Menstrual Manipulation for Adolescents With Disabilities

Number 448

(Reaffirmed 2012)

ABSTRACT: Defining the reasons for intervention and the precise goal of treatment are the most critical issues regarding use of interventions to alter menstrual flow in adolescents with disabilities....

December 2009

PDF Format
49.

Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign

Number 349

(Reaffirmed 2009)

ABSTRACT: Young patients and their parents often are unsure about what represents normal menstrual patterns, and clinicians also may be unsure about normal ranges for menstrual cycle length and amoun...

November 2006

PDF Format
50.

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT: Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country. Methamphetamine use in preg...

March 2011

PDF Format
51.

Misoprostol for Postabortion Care

Number 427

ABSTRACT: The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a ...

February 2009

PDF Format
52.

Müllerian Agenesis: Diagnosis, Management, and Treatment

Number 562

(Replaces No. 355, December 2006)

ABSTRACT: Müllerian agenesis occurs in 1 out of every 4,000–10,000 females. The most common presentation of müllerian agenesis is congenital absence of the vagina, uterus, or both, which also is refe...

May 2013

PDF Format
53.

Multifetal Pregnancy Reduction

Number 553

(Replaces Committee Opinion Number 369, June 2007)

ABSTRACT: Fertility treatments have contributed significantly to the increase in multifetal pregnancies. The first approach to the problem of multifetal pregnancies should be prevention, and strategi...

February 2013

PDF Format
54.

Nongynecologic Procedures

Number 253

(Reaffirmed 2013, Replaces Statement of Policy on Liposuction, January 1988)

Cosmetic procedures (such as laser hair removal, body piercing, tattoo removal, and liposuction) are not considered gynecologic procedures and, therefore, generally are not taught in approved obstetr...

March 2001

PDF Format
55.

OnabotulinumtoxinA and the Bladder

Number 604

ABSTRACT: In January 2013, the U.S. Food and Drug Administration approved the use of onabotulinumtoxinA (also known as Botox A) for the treatment of overactive bladder, thus providing another treatme...

June 2014

PDF Format
56.

Oocyte Cryopreservation

Number 584

ABSTRACT: In 2013, the American Society for Reproductive Medicine and the Society for Assisted Repro-ductive Technology published a joint document, Mature Oocyte Cryopreservation: A Guideline, which ...

January 2014

PDF Format
57.

Options for Prevention and Management of Heavy Menstrual Bleeding in Adolescent Patients Undergoing

Number 606

ABSTRACT: Adolescents undergoing cancer treatment are at high risk of heavy menstrual bleeding, and gynecologists may be consulted either before the initiation of cancer treatment to request strategi...

August 2014

PDF Format
58.

Oral Health Care During Pregnancy and Through the Lifespan

Number 569

ABSTRACT: Oral health is an important component of general health and should be maintained during pregnancy and through a woman’s lifespan. Maintaining good oral health may have a positive effect on ...

August 2013

PDF Format
59.

Over-the-Counter Access to Oral Contraceptives

Number 544

ABSTRACT: Unintended pregnancy remains a major public health problem in the United States. Access and cost issues are common reasons why women either do not use contraception or have gaps in use. A p...

December 2012

PDF Format
60.

Performance Enhancing Anabolic Steroid Abuse in Women

Number 484

(Reaffirmed 2013)

ABSTRACT: Anabolic steroids are composed of testosterone and other substances related to testosterone that promote growth of skeletal muscle, increase hemoglobin concentration, and mediate secondary ...

April 2011

PDF Format